Food News and Research

RSS

PBS NewsHour examines family planning in the Philippines

PBS NewsHour on Monday aired the second installment in its "Food for 9 Billion" series, in which "Sam Eaton of Homelands Productions goes to the fishing village of Humay-Humay" in the Philippines and "speaks with families about their concerns that future generations won't enjoy the same access to fish as a food staple and way of life," the PBS NewsHour blog "The Rundown" reports.

25 Jan 2012

Glanbia Nutritionals, ChromaDex sign LOI for pTeroPure

ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.

25 Jan 2012

Cohera receives FDA IDE approval to initiate U.S. clinical study for TissuGlu

Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that it has received Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration ("FDA") to begin a prospective, multicenter, randomized clinical trial for its lead product, TissuGlu Surgical Adhesive in the United States.

25 Jan 2012

One-year results from Covidien's EverFlex stent trial on P.A.D.

Covidien, a leading global provider of healthcare products, today announced that one-year results on the use of its EverFlex stent for superficial femoral artery stenting were presented here during the International Symposium on Endovascular Therapy (ISET) Conference.

25 Jan 2012

Enrollment complete in Medtronic's CoreValve U.S. Trial for severe aortic stenosis

Medtronic, Inc. today announced it has completed patient enrollment in the extreme risk study in its CoreValve U.S. Pivotal Trial. The company also received approval from the U.S. Food and Drug Administration (FDA) for an extended investigation to continue enrolling extreme risk patients under a Continued Access Study protocol.

From Medtronic 25 Jan 2012

Link between high fructose intake and cardiovascular risk in adolescents

Evidence of cardiovascular disease and diabetes risk is present in the blood of adolescents who consume a lot of fructose, a scenario that worsens in the face of excess belly fat, researchers report.

25 Jan 2012

Cocoa can help prevent onset of colon carcinogenesis

A new study on living animals has shown for the first time that eating cocoa (the raw material in chocolate) can help to prevent intestinal complaints linked to oxidative stress, including colon carcinogenesis onset caused by chemical substances.

24 Jan 2012

FDA approves Genzyme's Fabrazyme manufacturing plant in Framingham

Genzyme, a Sanofi company, announced today that the Food and Drug Administration (FDA) has approved its manufacturing plant in Framingham, Mass., for the production of Fabrazyme(agalsidase beta). This follows the previously announced approval by the European Medicines Agency (EMA) last week.

24 Jan 2012

Johnson & Johnson fourth quarter sales increase 3.9% to $16.3 billion

Johnson & Johnson today announced sales of $16.3 billion for the fourth quarter of 2011, an increase of 3.9% as compared to the fourth quarter of 2010. Operational sales increased 4.0% and the negative impact of currency was 0.1%.

24 Jan 2012

Studies indicate infant brains come equipped with knowledge of 'intuitive physics'

While it may appear that infants are helpless creatures that only blink, eat, cry and sleep, one University of Missouri researcher says that studies indicate infant brains come equipped with knowledge of "intuitive physics."

24 Jan 2012

Kids not getting enough Vitamin D

According to Dame Sally Davies, Chief Medical Officer (CMO) for England, young children and some adults are not getting enough vitamin D. Not receiving enough of the vitamin can lead to health problems including rickets, broken bones, muscle weakness and infections including TB. Research last year suggested that a quarter of Britain's toddlers did not have enough vitamin D in their bloodstreams.

24 Jan 2012

Heartburn drugs ineffective in kids with asthma: Study

A drug used to treat acid reflux has often been used for hard-to-treat asthma. A new study finds that it does not help children with the breathing disease and may cause side effects.

24 Jan 2012

Latest attacks in Jonglei, South Sudan, perpetuate a pattern of extreme violence, says Médecins Sans Frontières

In the state of Jonglei in South Sudan, civilians continue to bear the brunt of inter-communal fighting. Wounded patients are still arriving at the Médecins Sans Frontières hospital in Pibor, three weeks after the violent attack on the town and outlying villages in Pibor County. Many were injured in the bush, where thousands have remained, afraid to come out of hiding. Médecins Sans Frontières medical teams are now treating serious wound infections, some several weeks old. Since re-launching emergency medical activities in Pibor on 7 January, Médecins Sans Frontières has treated 47 patients with gunshot wounds – 16 women and 8 children. A further 43 patients have so far been treated for stab wounds, beatings or wounds sustained while fleeing in the bush.

24 Jan 2012

Dutaseride may help prevent progression of early stage prostate cancer: Study

A new study suggests that men with early stage prostate cancer may benefit with drugs that can slow or stop the cancer’s progress. Less than 10 percent of the 100,000 men each year who are diagnosed with early-stage prostate cancer and have the option of leaving the cancer in place. Rest get it removed using surgery or radiation. But those treatments can have serious side effects like impotence and incontinence.

24 Jan 2012

Aquilent awarded new IT contracts by the HHS

Aquilent, the recognized leading provider of Web-based solutions shaping the next generation of technology for the federal government, today announced it has been awarded more than a dozen new contracts within the past several months supporting numerous operating divisions and programs within the U.S. Department of Health and Human Services (HHS).

24 Jan 2012

UNL project to reduce Shiga-toxin producing E. coli threat

The University of Nebraska-Lincoln will lead a $25 million project to reduce throughout the beef production chain the occurrence of E. coli strains that pose a major threat to public health.

24 Jan 2012

InSightec seeks FDA premarket approval for ExAblate treatment of pain palliation of bone metastases

InSightec Ltd, the leader in MR guided Focused Ultrasound therapy, announced that it has submitted a premarket approval application (PMA) to the U.S. Food and Drug Administration (FDA) for its ExAblate treatment of pain palliation of bone metastases.

24 Jan 2012

Viewpoints: Opposing views of HHS' contraception rule; Health care costs and the liberal agenda

The administration's rule leaves the decision in the hands of patients, where it belongs, while respecting the rights of religions. It holds true to the original and wise idea that access to preventive medicine is a good idea for the nation's physical and financial well-being.

24 Jan 2012

CQA derivatives in mate tea kill human colon cancer cells

Could preventing colon cancer be as simple as developing a taste for yerba mate tea? In a recent University of Illinois study, scientists showed that human colon cancer cells die when they are exposed to the approximate number of bioactive compounds present in one cup of this brew, which has long been consumed in South America for its medicinal properties.

24 Jan 2012

Perrigo files ANDA and confirms Astepro Nasal Spray patent challenge

Perrigo Company announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for azelastine hydrochloride nasal spray (0.15%) and has notified Meda Pharmaceuticals, Inc., the owner of the New Drug Application (NDA) of its filing. The ANDA filing involved contributions from both Perrigo and Impax Laboratories, Inc., who will share costs and benefits of this project.

24 Jan 2012